National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

recombinant vaccinia-MUC-1 vaccine
A vaccine containing a recombinant vaccinia virus that encodes the gene for human mucin-1, a tumor-associated antigen. Upon administration, recombinant vaccinia-MUC-1 vaccine may elicit a MUC-1-specific cytotoxic T cell response against tumor cells bearing MUC-1. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonyms:rV-MUC-1 vaccine
vaccinia-MUC-1 vaccine
Abbreviation:rV-MUC-1



Previous:recombinant tumor necrosis factor family protein, recombinant tyrosinase-related protein-2, recombinant vaccinia prostate-specific antigen vaccine, recombinant vaccinia-B7.1 vaccine, recombinant vaccinia-CEA(6D)-TRICOM vaccine
Next:recombinant vaccinia-multiepitope melanoma peptides-B7.1-B7.2 vaccine, recombinant vaccinia-NY-ESO-1 vaccine, recombinant vaccinia-TRICOM vaccine, Rectoid, reduced glutathione-L-cysteine-anthocyanins gel

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov